Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity in Delaware
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Delaware
| Provider | Medicare | Services |
|---|---|---|
| Sampathkumar, Haresh MD | $90.91 | 60 |
Delaware Pricing in Context
In Delaware, CPT code 64645 (Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity) carries an average Medicare payment of $90.98 — 10% above the national benchmark of $82.42. 2 providers across the state submitted claims for this procedure in 2023, performing 61 total services. Individual payments in DE ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Delaware is $249.62, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Delaware sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Nervous System Surgery procedures, the estimated commercial insurance price in Delaware lands near $256.94, with self-pay cash prices typically around $154.29. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity cost in Delaware?
The average Medicare payment for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity in Delaware is $90.98, which is 10% above the national average of $82.42. Providers in DE typically bill $249.62 for this procedure.
What does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity cost with insurance in Delaware?
With commercial insurance in Delaware, Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity costs an estimated $256.94. Without insurance, the estimated cash price is $154.29. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity in Delaware?
2 providers in Delaware billed Medicare for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity in 2023, performing 61 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity cheaper in Delaware than the national average?
No — Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 5 Or More Muscles, Each Additional Extremity costs 10% above the national average in Delaware. The state average Medicare payment is $90.98 compared to $82.42 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.